DE69943225D1 - Flüssige Polymerlosung zur Kontrollierten freisetzung von bioaktiven substanzen - Google Patents

Flüssige Polymerlosung zur Kontrollierten freisetzung von bioaktiven substanzen

Info

Publication number
DE69943225D1
DE69943225D1 DE69943225T DE69943225T DE69943225D1 DE 69943225 D1 DE69943225 D1 DE 69943225D1 DE 69943225 T DE69943225 T DE 69943225T DE 69943225 T DE69943225 T DE 69943225T DE 69943225 D1 DE69943225 D1 DE 69943225D1
Authority
DE
Germany
Prior art keywords
controlled release
polymer solution
liquid polymer
bioactive substances
casing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69943225T
Other languages
English (en)
Inventor
Rey T Chern
Joel R Zingerman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Sharp and Dohme LLC
Original Assignee
Merck Sharp and Dohme LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Sharp and Dohme LLC filed Critical Merck Sharp and Dohme LLC
Application granted granted Critical
Publication of DE69943225D1 publication Critical patent/DE69943225D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Inorganic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
DE69943225T 1998-03-19 1999-03-18 Flüssige Polymerlosung zur Kontrollierten freisetzung von bioaktiven substanzen Expired - Lifetime DE69943225D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US7957498P 1998-03-19 1998-03-19
GBGB9815801.7A GB9815801D0 (en) 1998-07-21 1998-07-21 Liquid polymeric compositions for controlled released bioactive substances

Publications (1)

Publication Number Publication Date
DE69943225D1 true DE69943225D1 (de) 2011-04-07

Family

ID=10835852

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69943225T Expired - Lifetime DE69943225D1 (de) 1998-03-19 1999-03-18 Flüssige Polymerlosung zur Kontrollierten freisetzung von bioaktiven substanzen

Country Status (10)

Country Link
JP (1) JP4829405B2 (de)
AT (1) ATE499069T1 (de)
DE (1) DE69943225D1 (de)
DK (1) DK1484033T3 (de)
GB (1) GB9815801D0 (de)
GE (1) GEP20033012B (de)
PT (1) PT1484033E (de)
RS (1) RS49840B (de)
SI (1) SI1484033T1 (de)
UA (1) UA53788C2 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8362086B2 (en) * 2005-08-19 2013-01-29 Merial Limited Long acting injectable formulations
CN104168886A (zh) * 2012-03-13 2014-11-26 拜耳新西兰有限公司 长效组合物
KR20220108207A (ko) * 2013-09-16 2022-08-02 머크 샤프 앤드 돔 코포레이션 Cgrp 수용체 길항제를 위한 제제
KR102101969B1 (ko) * 2017-09-06 2020-04-22 (주)인벤티지랩 목시덱틴을 포함하는 마이크로 입자 및 이의 제조 방법

Also Published As

Publication number Publication date
PT1484033E (pt) 2011-04-21
RS49840B (sr) 2008-08-07
GB9815801D0 (en) 1998-09-16
GEP20033012B (en) 2003-07-25
YU54100A (sh) 2002-11-15
JP2002506797A (ja) 2002-03-05
SI1484033T1 (sl) 2011-06-30
DK1484033T3 (da) 2011-06-14
UA53788C2 (uk) 2003-02-17
JP4829405B2 (ja) 2011-12-07
ATE499069T1 (de) 2011-03-15

Similar Documents

Publication Publication Date Title
ATE269676T1 (de) Flüssige polymerlosung zur kontrollierten freisetzung von bioaktiven substanzen
DE69121675T2 (de) Mikrosphäre enthaltende pharmazeutische Zusammensetzung mit kontrollierter Freigabe und Verfahren zur Herstellung
HUP9904174A2 (hu) Bőrön át történő adagoláshoz szánt gyógyszerkészítmények
DE60023520D1 (de) Flüssiges hochvisköses system mit gesteuerter freisetzung und medizinische oder chirurgische vorrichtung
DE69930240D1 (de) Matrizes gebildet aus polymer und hydrophoben verbindungen zur verwendung bei der freisetzung von arzneimitteln
DE69623087D1 (de) Brausemittel und dessen Herstellung
MY118835A (en) Sustained release compositions and the process for their preparation
FI932761A0 (fi) Foerfarande foer framstaellning av aktiva substanser innehaollande mikropartiklar av hydrolytiskt nedbrytbara polymerer
BR9607752A (pt) Formulação farmacêutica de microcápsula de liberação controlada, processo para sua preparação, e, processo de uso das microcápsulas
ATE210427T1 (de) Verfahren zur herstellung von arzneimittelenthaltenden gefriergetrockneten formulierungen
ES2019658B3 (es) Procedimiento de bombeo para la mezcla artificial de dos liquidos en cantidades iguales y dispositivo de bombeo para efectuar este procedimiento.
DE59506057D1 (de) Kollagenzubereitung zur gesteuerten abgabe von wirkstoffen
DE69007714D1 (de) Pharmazeutische Zubereitung mit antitumoraler Wirkung und Verfahren zur Herstellung.
SE9704400D0 (sv) Porous inorganic particles as carriers for drug substances
ATE281155T1 (de) Medikamentöse verabreichung von proteinen aus polymergemischen
DE69943225D1 (de) Flüssige Polymerlosung zur Kontrollierten freisetzung von bioaktiven substanzen
BR9712904A (pt) Agentes de tratamento de plantas
BR9102497A (pt) Processo para revestimento,usando uma composicao a base de polimero sensivel ao ph,principios ativos medicinais e/ou alimenticios
SE8601563D0 (sv) Matrismaterial, forfarande for framstellning derav och anvendning derav
GR1000266B (el) Μεθοδος παρασκευης μιας συνθεσης βασισμενης σε πολυεστερα για την ελεγχομενη εκλυση φαρμακευτικων ουσιων.

Legal Events

Date Code Title Description
R081 Change of applicant/patentee

Ref document number: 1484033

Country of ref document: EP

Owner name: SCHERING CORPORATION, US

Free format text: FORMER OWNER: MERCK SHARP & DOHME CORP., RAHWAY, US

Effective date: 20121213

R082 Change of representative

Ref document number: 1484033

Country of ref document: EP

Representative=s name: ABITZ & PARTNER, DE

Effective date: 20121213